CD22 CAR T Cells Show Relatively Mild Neurotoxicity, Study F

Investigators found important differences that may help clinicians better understand how to manage toxicities associated with the therapy.

Related Keywords

Niralin Shah , , National Institutes Of Health Cancer Institute , National Institutes , National Cancer Institute ,